(Q40706221)

22 September 2017

title

Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte (English)

1 reference

22 September 2017

0 references

6

1 reference

22 September 2017

Tom Nijenhuis

9

0 references

Johan Van Der Vlag

object named as

Johan van der Vlag

10

0 references

author name string

Marjolein Garsen

1

1 reference

22 September 2017

Ramon Sonneveld

2

1 reference

22 September 2017

Angelique L W M M Rops

3

1 reference

22 September 2017

Suzanne Huntink

4

1 reference

22 September 2017

Toin H van Kuppevelt

5

1 reference

22 September 2017

Joost G J Hoenderop

7

1 reference

22 September 2017

Jo H M Berden

8

1 reference

22 September 2017

publication date

23 July 2015

1 reference

22 September 2017

1 reference

22 September 2017

volume

237

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

472-481

1 reference

The role of heparanase and the endothelial glycocalyx in the development of proteinuria

22 September 2017

cites work

1 reference

Heparanase in glomerular diseases

21 January 2018

1 reference

New approaches to the treatment of dense deposit disease

21 January 2018

1 reference

Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.

21 January 2018

1 reference

Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.

21 January 2018

1 reference

Heparanase is essential for the development of diabetic nephropathy in mice.

21 January 2018

1 reference

Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms

21 January 2018

1 reference

Active vitamin D treatment for reduction of residual proteinuria: a systematic review

21 January 2018

1 reference

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

21 January 2018

1 reference

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

21 January 2018

1 reference

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

21 January 2018

1 reference

Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.

21 January 2018

1 reference

1,25-Dihydroxyvitamin D3decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat

21 January 2018

1 reference

1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss

21 January 2018

1 reference

Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1alpha-hydroxylase knockout mice

21 January 2018

1 reference

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney

21 January 2018

1 reference

Isolation and characterization of conditionally immortalized mouse glomerular endothelial cell lines

21 January 2018

1 reference

Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

21 January 2018

1 reference

Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity

21 January 2018

1 reference

Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.

21 January 2018

1 reference

Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

21 January 2018

1 reference

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells

21 January 2018

1 reference

Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice

21 January 2018

1 reference

Nephroprotective effect of heparanase in experimental nephrotic syndrome

21 January 2018

1 reference

Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.

21 January 2018

1 reference

Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation

21 January 2018

1 reference

Role of vascular endothelial growth factor in kidney disease.

21 January 2018

1 reference

Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy

21 January 2018

1 reference

Effects of vitamin D3 on expression of tumor necrosis factor-alpha and chemokines by monocytes

21 January 2018

1 reference

Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling

21 January 2018

1 reference

Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking.

21 January 2018

1 reference

Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice

21 January 2018

1 reference

Adriamycin alters glomerular endothelium to induce proteinuria

21 January 2018

1 reference

Identification of the vitamin D receptor in various cells of the mouse kidney

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.4593

1 reference

22 September 2017

1 reference